Silo Pharma - SILO Net Assets per Single Share

Graphic logo of Silo Pharma, Inc. (SILO)

Silo Pharma, Inc. (SILO) is developing psilocybin-based drugs to combat PTSD and Alzheimer's disease. Management is betting on microdosing to treat inflammatory processes in the nervous system. Business success depends on clinical trials of antidepressants and stable R&D funding. The actual book value per share has settled at 4.31, as clearly demonstrated by the price action on this chart.

silopharma.com (SILO): Share Book Value from 04/28/2023 to 10/28/2026

silopharma.com - analytical breakdowns and key metrics (SILO)

- price and consensus price forecast:
Price Chart Silo Pharma, Inc.|SILO - Price Target Chart
- market capitalization data:
Market Value Silo Pharma, Inc.|SILO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Silo Pharma|SILO - Net Asset Value|Market Capitalization to Book Value Ratio silopharma.com|SILO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Silo Pharma, Inc.|SILO - Long-Term Debt to Capital|Short-Term Debt to Equity Silo Pharma|SILO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Silo Pharma, Inc.|SILO - Company Long-Term Liabilities|Company Short-Term Debts Silo Pharma
Fundamental company valuation:Silo Pharma, Inc. - SILO
Manufactured products of Silo Pharma

Book value per share determines the residual tangible value of capital minus all liabilities, serving as a measure of an investor's real assets. When analyzing the book value of capital per share for Silo Pharma, Inc. (SILO), it is essential to consider that intangible assets and intellectual property play a key role in the biopharmaceutical sector, as they are critical for navigating R&D phases and securing FDA approval.

Competitors of Silo Pharma, Inc. (SILO)

ALKS - Net Assets per Single Share|AVDL: Net Assets per Single Share|Net Assets per Single Share ATAI|GHRS (ghres.com) - Net Asset Value per Share|Net Assets per Single Share MindMed MNMD|Share Book Value COMPASS Pathways PLC|LB Pharma (LBRX) - Book Value per Share|Accounting Value of a Share Bright Minds Corp (DRUG)|Book Value per Share VNDA (Vanda Pharmaceuticals)|Cybin Inc - Book Value per Share|Net Assets per Single Share Alto Neuroscience (ANRO)|NRXP: Accounting Value of a Share|CING (cingulate.com) - Net Assets per Single Share|China Pharma Holdings, Inc. (CPHI) - Accounting Value per Share|CMND (Clearmind Medicine) - Book Value per Share|Book Value per Share pacificbayminerals.com (PBM)|SciSparc (SPRC) - Accounting Value per Share|Accounting Value of a Share SEEL (Seelos Therapeutics Inc.)|Virpax Pharmaceuticals, Inc. (VRPX) - Net Assets per Single Share|Karuna Pharma - Share Book Value